Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Study ID
NCT04867915
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL. retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021. prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.

Key Dates

First listed
Apr 30, 2021
Start date
Oct 13, 2021
Status verified
Mar 2025
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
12,500 participants (estimated)

Primary Outcome Measure

Describe the diagnosis and management of CLL patients [ Time Frame: at 1 year for the prospective cohort and at 4 years for the retrospective cohort ]

Central Contacts

Find similar trials

Related Studies